(5-Oxo-2,5-dihydro-1H-pyrazol-3-yl)-acetic acid is used as a reactant in the design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors.
